Baxter Retained Earnings (Accumulated Deficit) 2010-2025 | BAX
Baxter retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Baxter retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $14.968B, a 6.47% decline year-over-year.
- Baxter retained earnings (accumulated deficit) for 2024 were $14.929B, a 7.35% decline from 2023.
- Baxter retained earnings (accumulated deficit) for 2023 were $16.114B, a 14.69% increase from 2022.
- Baxter retained earnings (accumulated deficit) for 2022 were $14.05B, a 17.67% decline from 2021.
| Baxter Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $14,929 |
| 2023 | $16,114 |
| 2022 | $14,050 |
| 2021 | $17,065 |
| 2020 | $16,328 |
| 2019 | $15,718 |
| 2018 | $15,075 |
| 2017 | $14,483 |
| 2016 | $14,200 |
| 2015 | $9,683 |
| 2014 | $13,227 |
| 2013 | $11,852 |
| 2012 | $10,888 |
| 2011 | $9,429 |
| 2010 | $7,925 |
| 2009 | $7,343 |
| Baxter Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $14,968 |
| 2024-12-31 | $14,929 |
| 2024-09-30 | $15,529 |
| 2024-06-30 | $15,539 |
| 2024-03-31 | $16,003 |
| 2023-12-31 | $16,114 |
| 2023-09-30 | $16,015 |
| 2023-06-30 | $13,655 |
| 2023-03-31 | $13,947 |
| 2022-12-31 | $14,050 |
| 2022-09-30 | $14,015 |
| 2022-06-30 | $17,099 |
| 2022-03-31 | $16,994 |
| 2021-12-31 | $17,065 |
| 2021-09-30 | $16,967 |
| 2021-06-30 | $16,658 |
| 2021-03-31 | $16,502 |
| 2020-12-31 | $16,328 |
| 2020-09-30 | $16,285 |
| 2020-06-30 | $16,055 |
| 2020-03-31 | $15,935 |
| 2019-12-31 | $15,718 |
| 2019-09-30 | $15,849 |
| 2019-06-30 | $16,184 |
| 2019-03-31 | $15,970 |
| 2018-12-31 | $15,075 |
| 2018-09-30 | $15,394 |
| 2018-06-30 | $14,966 |
| 2018-03-31 | $14,734 |
| 2017-12-31 | $14,483 |
| 2017-09-30 | $14,615 |
| 2017-06-30 | $14,480 |
| 2017-03-31 | $14,323 |
| 2016-12-31 | $14,200 |
| 2016-09-30 | $14,049 |
| 2016-06-30 | $14,037 |
| 2016-03-31 | $12,923 |
| 2015-12-31 | $9,683 |
| 2015-09-30 | $9,578 |
| 2015-06-30 | $13,389 |
| 2015-03-31 | $13,352 |
| 2014-12-31 | $13,227 |
| 2014-09-30 | $12,563 |
| 2014-06-30 | $12,378 |
| 2014-03-31 | $12,142 |
| 2013-12-31 | $11,852 |
| 2013-09-30 | $11,792 |
| 2013-06-30 | $11,517 |
| 2013-03-31 | $11,194 |
| 2012-12-31 | $10,888 |
| 2012-09-30 | $10,642 |
| 2012-06-30 | $10,306 |
| 2012-03-31 | $9,831 |
| 2011-12-31 | $9,429 |
| 2011-09-30 | $9,154 |
| 2011-06-30 | $8,754 |
| 2011-03-31 | $8,316 |
| 2010-12-31 | $7,925 |
| 2010-09-30 | $7,717 |
| 2010-06-30 | $7,376 |
| 2010-03-31 | $7,030 |
| 2009-12-31 | $7,343 |
| 2009-09-30 | $6,954 |
| 2009-06-30 | $6,580 |
| 2009-03-31 | $6,152 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.247B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.881B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.673B | 27.69 |
| ResMed (RMD) | United States | $36.905B | 27.72 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |